Effectiveness of Toothpaste Containing the Active Ingredient of Galla Chinensis Extract on Treating Dentin Hypersensitivity
1 other identifier
interventional
90
1 country
1
Brief Summary
This clinical trial was conducted to compare the desensitizing effect of toothpaste containing the active ingredient of an extract of Galla chinensis and toothpaste containing fluoride in patients with dentin hypersensitivity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 23, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 25, 2022
CompletedFirst Submitted
Initial submission to the registry
July 28, 2022
CompletedFirst Posted
Study publicly available on registry
August 1, 2022
CompletedOctober 18, 2023
October 1, 2023
6 months
July 28, 2022
October 17, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change of pain level in response to stimuli
Teeth were evaluated at baseline (T0), 1week (T1), 2 weeks (T2), 4 weeks (T3), 3 months (T4), and 6 months (T5) after using different types of toothpastes using Visual Analog Scale (VAS) scoring from 0-10 while 0 mean no pain and 10 severe pain by sensitivity tests (schiff test )
6 months follow up
Study Arms (2)
toothpaste with active ingredient of galla chinensis
EXPERIMENTALtoothpaste with stannous fluoride
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Age \>18 years.
- Overall good oral hygiene status.
- Participants show tooth neck abrasion or gingival retraction.
- Patients have subjective dentin hypersensitivity (at least 1 tooth) after using airflow.
- No history of periodontal treatment, including periodontal surgery, in the past year.
- Written informed consent
You may not qualify if:
- Patient with severe periodontitis or severe erosion damage.
- Patients with a compromised medical history, or had received therapeutic irradiation to the head and neck region.
- Medically compromised patients where pain levels would be compromised.
- If analgesics or antibiotics have been administrated by the patient during the past 12 hours preoperatively as it might alter their pain perception.
- Patients reporting bruxism or clenching in order to avoid further pressure on an already hypersensitive tooth inducing subsequent irritation and inflammation.
- Teeth that show association with acute periapical abscess and swelling.
- Greater than grade I mobility or pocket depth greater than 5mm.
- Non-restorable teeth or hopeless teeth.
- Immature teeth.
- Radiographic evidence of external or internal root resorption.
- Alcoholic and smoker patients.
- Pregnant or breastfeeding ladies.
- Patients having physical disabilities, or who are unable to brush their teeth
- Patients who have a history of allergies to any personal oral care product or ingredient, or who are taking anti-inflammatory drugs within the previous month.
- Individuals who had sensitive teeth but with one of the following conditions will be excluded from the study, teeth with large restorations, abutment of teeth of removable partial dentures, dental caries, enamel cracks, leakage of fillings or other restorations, cracked 23
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Minia Universitylead
Study Sites (1)
Faculty of Dentistry
Minya, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
July 28, 2022
First Posted
August 1, 2022
Study Start
May 20, 2021
Primary Completion
November 23, 2021
Study Completion
June 25, 2022
Last Updated
October 18, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will share